Monocyte-mediated T cell suppression by HIV-2 envelope proteins

European Journal of Immunology

Volumn 37, Issue 12, 2007, Pages 3435-3444

  Cavaleiro, Rita ^a   Brunn, Gregory J ^b   Albuquerque, Adriana S ^a   Victorino, Rui M M ^a   Platt, Jeffrey L ^c   de Sousa, Ana Espada ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

HIV; Host pathogen interactions; Immunopathology; Monocytes; Toll like receptors

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 2 ENVELOPE PROTEIN GP 105; MICROSOMAL AMINOPEPTIDASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE; VIREMIA; VIRUS VIRULENCE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELL COMMUNICATION; CELLS, CULTURED; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-2; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MONOCYTES; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTOR 4; VIRULENCE;

EID: 37549025374     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737511     Document Type: Article

References (58)

1. Chirmule, N. and Pahwa, S., Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions. Microbiol. Rev. 1996. 60: 386-406.
2. William, M. A., Trout, R. and Spector, S. A., HIV-1 gp120 modulates the immunological function and expression of accessory and co-stimulatory molecules of monocyte-derived dendritic cells. J. Hematother. Stem Cell. Res. 2002. 11: 829-847.
3. Fantuzzi, L., Purificato, C., Donato, K., Belardelli, F. and Gessani, S., Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: A novel mechanism for AIDS pathogenesis. J. Virol. 2004. 78: 9763-9772.
4. He, B., Qiao, X., Klasse, P. J., Chiu, A., Chadburn, A., Knowles, D. M., Moore, J. P. and Cerutti, A., HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 2006. 176: 3931-3941.
5. Kottilil, S., Shin, K., Jackson, J. O., Reitano, K. N., O'Shea, M. A., Yang, J., Hallahan, C. W. et al., Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions. J. Immunol. 2006. 176: 1107-1114.
6. + T cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007. 109: 3351-3359.
7. Martinelli, E., Cicala, C., Van Ryk, D., Goode, D. J., Macleod, K., Arthos, J. and Fauci, A. S., HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 2007. 104: 3396-3401.
8. Lee, C., Liu, Q. H., Tomkowicz, B., Yi, Y., Freedman, B. D. and Collman R. G., Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. J. Leukoc. Biol. 2003. 74: 676-682.
9. Cicala, C., Arthos, J., Martinelli, E., Censoplano, N., Cruz, C. C., Chung, E., Selig, S. M. et al., R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. Proc. Natl. Acad. Sci. USA 2006. 103: 3746-3751.
10. Oh, S. K., Cruikshank, W. W., Raina, J., Blanchard, G. C., Adler, W. H., Walker, J. and Kornfeld, H., Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquir. Immune Defic. Syndr. 1992. 5: 251-256.
11. Poulsen, A. G., Aaby, P., Larsen, O., Jensen, H., Nauder, A., Lisse, I. M., Christiansen, C. B. et al., 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997. 349: 911-914.
12. Marlink, R., Kanki, P., Thior, I., Travers, K., Eisen, G., Siby, T., Traore, I. et al., Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994. 265: 1587-1590.
13. + cells is faster in HIV-1 than in HIV-2 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997. 16: 327-332.
14. Sousa, A. E., Chaves, A. F., Loureiro, A. and Victorino, R. M., Comparison of the frequency of interleukin-2, interferon-γ and interleukin-4 producing T cells in two diseases with distinct clinical outcomes: The human immunodeficiency virus type 1 and 2 infections. J. Infect. Dis. 2001. 184: 552-559.
15. Reeves, J. D. and Doms, R. W., Human immunodeficiency virus type 2. J. Gen. Virol. 2002. 83: 1253-1265.
16. Grossman, Z., Meier-Schellersheim, M., Sousa, A. E., Victorino, R. M. and Paul, W. E., CD4 T cell depletion in HIV infection: Are we closer to understanding the cause? Nat. Med. 2002. 8: 319-323.
17. Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z. and Victorino, R. M., CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 2002. 169: 3400-3406.
18. + T cells in human immunodeficiency virus type 2 infection. J. Virol. 2006. 80: 12425-12429.
19. Albuquerque, A. S., Cortesao, C. S., Foxall, R. B., Soares, R. S., Victorino, R. M. and Sousa, A. E., Rate of increase in circulating IL-7 and loss of IL-7Ralpha expression differ in HIV-1 and HIV-2 infections: Two lymphopenic diseases with similar hyperimmune activation but distinct outcomes. J. Immunol. 2007. 178: 3252-3259.
20. Rowland-Jones, S. L. and Whittle, H. C., Out of Africa: What can we learn from HIV-2 about protective immunity to HIV-1? Nat. Immunol. 2007. 8: 329-331.
21. Azevedo-Pereira, J. M., Santos-Costa, Q. and Moniz-Pereira, J., HIV-2 infection and chemokine receptors usage - clues to reduced virulence of HIV-2. Curr. HIV Res. 2005. 3: 3-16.
22. Bjorling, E., Scarlatti, G., von Gegerfelt, A., Albert, J., Biberfeld, G., Chiodi, F., Norrby, E. and Fenyo, E. M., Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 1993. 193: 528-530.
23. Kaneko, H., Neoh, L. P., Takeda, N., Akimoto, H., Hishikawa, T., Hashimoto, H., Hirose, S. et al., Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells. J. Virol. 1997. 71: 8918-8922.
24. Taveira, N. C., Bex, F., Burny, A., Robertson, D., Ferreira, M. O. and Moniz-Pereira, J., Molecular characterization of the env gene from a non-syncytium- inducing HIV-2 isolate (HIV-2ALI). AIDS Res. Hum. Retroviruses 1994. 10: 223-224.
25. Cavaleiro, R., Sousa, A. E., Loureiro, A. and Victorino, R. M., Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS 2000. 14: 2679-2686.
26. Rouse, B. T., Sarangi, P. P. and Suvas, S., Regulatory T cells in virus infections. Immunol. Rev. 2006. 212: 272-286.
27. Birdsall, H. H., Porter, W. J., Trial, J. and Rossen, R. D., Monocytes stimulated by 110-kDa fibronectin fragments suppress proliferation of anti-CD3-activated T cells. J. Immunol. 2005. 175: 3347-3353.
28. Brunn, G. J., Bungum, M. K., Johnson, G. B. and Platt, J. L., Conditional signaling by Toll-like receptor 4. FASEB J. 2005. 19: 872-874.
29. Johnson, G. B., Brunn, G. J. and Platt, J. L., Cutting edge: An endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J. Immunol. 2004. 172: 20-24.
30. + T cell levels: Results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 1993. 6: 904-912.
31. Ostrowski, M. A., Krakauer, D. C., Li, Y., Justement, S. J., Learn, G., Ehler, L. A., Stanley, S. K. et al., Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J. Virol. 1998. 72: 7772-7784.
32. Hazenberg, M. D., Otto, S. A., van Benthem, B. H., Roos, M. T., Coutinho, R. A., Lange, J. M., Hamann, D. et al., Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003. 17: 1881-1888.
33. Silvestri, G., Sodora, D. L., Koup, R. A., Palardini, M., O'Neil, S. P., McClure, H. M., Staprans, S. I. and Feinberg, M. B., Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003. 18: 441-452.
34. + T cell changes independent of viral load. Blood 2004. 104: 942-947.
35. Rodriguez, B., Sethi, A. K., Cheruvu, V. K., Mackay, W., Bosch, R. J., Kitahata, M., Boswell, S. L et al., Predictive value of plasma HIV RNA level on rate of CD4 T cell decline in untreated HIV infection. JAMA 2006. 296: 1498-1506.
36. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z. et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006. 12: 1365-1371.
37. Noursadeghi, M., Katz, D. R. and Miller, R. F., HIV-1 infection of mononuclear phagocytic cells: The case for bacterial innate immune deficiency in AIDS. Lancet Infect. Dis. 2006. 6: 794-804.
38. Bertholet, S., Dickensheets, H. L., Sheikh, F., Gam, A. A., Donnelly, R. P. and Kenney, R. T., Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: A novel mechanism for intracellular parasite suppression of activation. Infect. Immun. 2003. 71: 2095-2101.
39. Nagabhushanam, V., Solache, A., Ting, L. M., Escaron, C. J., Zhang, J. Y. and Ernst, J. D., Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J. Immunol. 2003. 171: 4750-4757.
40. Shimizu, T., Sano, C. and Tomioka, H., The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection. Clin. Exp. Immunol. 2004. 135: 373-379.
41. Dolganiuc, A., Chang, S., Kodys, K., Mandrekar, P., Bakis, G., Cormier, M. and Szabo, G., Hepatitis C virus (HCV) core protein-induced, monocyte mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 2006. 177: 6758-6768.
42. Smits, H. H., de Jong, E. C., Wierenga, E. A. and Kapsenberg, M. L., Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 2005. 26: 123-129.
43. + regulatory T cells. Hum. Immunol. 2005. 66: 222-230.
44. Hoves, S., Krause, S. W., Schutz, C., Halbritter, D., Scholmerich, J., Herfarth, H. and Fleck, M., Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J. Immunol. 2006. 177: 2691-2698.
45. + T cell survival in HIV infection. J. Exp. Med. 2006. 203: 2281-2292.
46. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 2004. 172: 4676-4680.
47. Jude, B. A., Pobezinskaya, Y., Bishop, J., Parke, S., Medzhitov, R. M., Chervonsky, A. V. and Golovkina, T. V., Subversion of the innate immune system by a retrovirus. Nat. Immunol. 2003. 4: 573-578.
48. Perry, J. A., Olver, C. S., Burnett, R. C. and Avery, A. C., Cutting edge: The acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 2005. 174: 5921-5925.
49. Rassa, J. C., Meyers, J. L., Zhang, Y., Kudaravalli, R. and Ross, S. R., Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 2002. 99: 2281-2286.
50. Triantafilou, M., Miyake, K., Golenbock, D. T. and Triantafilou, K., Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 2002. 115: 2603-2611.
51. Kishore, S. P., Bungum, M. K., Platt, J. L. and Brunn, G. J., Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4. FEBS Lett. 2005. 579: 699-704.
52. Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L. and Alizon, M., Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987. 326: 662-669.
53. Hirsch, V. M., Olmsted, R. A., Murphey-Corb, M., Purcell, R. H. and Johnson, P. R., An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989. 339: 389-392.
54. Silvestri, G., Fedanov, A., Germon, S., Kozyr, N., Kaiser, W. J., Garber, D. A., McClure, H. et al., Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 2005. 79: 4043-4054.
55. Schramm, B., Penn, M. L., Palacios, E. H., Grant, R. M., Kirchhoff, F. and Goldsmith, M. A., Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J. Virol. 2000. 74: 9594-9600.
56. + T cells. J. Exp. Med. 2005. 201: 2023-2033.
57. Grossman, Z., Polis, M., Feinberg, M. B., Levi, I., Jankelevich, S., Yarchoan, R., Boon, J. et al., Ongoing HIV dissemination during HAART. Nat. Med. 1999. 5: 1099-1104.
58. Paya, C. V., Ten, R. M., Bessia, C., Alcami, J., Hay, R. T. and Virelizier, J. L., NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc. Natl. Acad. Sci. USA 1992. 89: 7826-7830.